Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial

Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the SBRT and nivolumab study is now displayed, with its completed status, study design, eligibility criteria, interventions, outcome measures, and study documents.
    Difference
    57%
    Check dated 2026-11-08T14:32:36.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:58.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH agencies are transitioning to use “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:40:09.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:16:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer identifies the site as revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:57:51.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page. A large portion of the Study Documents and related links, including PDFs and protocol documents, were removed, reducing access to supporting materials for the study.
    Difference
    20%
    Check dated 2026-09-20T22:25:51.000Z thumbnail image

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.